A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium (Q33409392)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium |
scientific article |
Statements
1 reference
A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium (English)
1 reference
Alexandra P Zorzi
1 reference
Mark Bernstein
1 reference
Yvan Samson
1 reference
Donna A Wall
1 reference
Sunil Desai
1 reference
Darcy Nicksy
1 reference
Nancy Wainman
1 reference
Elizabeth Eisenhauer
1 reference
Sylvain Baruchel
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference